BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26495840)

  • 1. Apolipoprotein E e4 and Cognitive Function: A Modifiable Association Results from Two Independent Cohort Studies.
    Perna L; Mons U; Rujescu D; Kliegel M; Brenner H
    Dement Geriatr Cogn Disord; 2016; 41(1-2):35-45. PubMed ID: 26495840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype.
    Yasuno F; Tanimukai S; Sasaki M; Hidaka S; Ikejima C; Yamashita F; Kodama C; Mizukami K; Michikawa M; Asada T
    Am J Geriatr Psychiatry; 2012 Jul; 20(7):574-83. PubMed ID: 21407046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine and cognitive performance: modification by the ApoE genotype.
    Elias MF; Robbins MA; Budge MM; Elias PK; Dore GA; Brennan SL; Johnston C; Nagy Z
    Neurosci Lett; 2008 Jan; 430(1):64-9. PubMed ID: 18023533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of apolipoproteins e4 and c1 with onset age and memory: a study of sporadic Alzheimer disease in Taiwan.
    Chuang WL; Hsieh YC; Wang CY; Kuo HC; Huang CC
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):42-8. PubMed ID: 20145290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the apolipoprotein E genotype on response to personalized dietary advice intervention: findings from the Food4Me randomized controlled trial.
    Fallaize R; Celis-Morales C; Macready AL; Marsaux CF; Forster H; O'Donovan C; Woolhead C; San-Cristobal R; Kolossa S; Hallmann J; Mavrogianni C; Surwillo A; Livingstone KM; Moschonis G; Navas-Carretero S; Walsh MC; Gibney ER; Brennan L; Bouwman J; Grimaldi K; Manios Y; Traczyk I; Drevon CA; Martinez JA; Daniel H; Saris WH; Gibney MJ; Mathers JC; Lovegrove JA;
    Am J Clin Nutr; 2016 Sep; 104(3):827-36. PubMed ID: 27510539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does an Alzheimer's disease susceptibility gene influence the cognitive effects of cancer therapy?
    Caselli RJ
    Pediatr Blood Cancer; 2014 Oct; 61(10):1739-42. PubMed ID: 24106134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apolipoprotein E gene and its age-specific effects on cognitive function.
    Liu F; Pardo LM; Schuur M; Sanchez-Juan P; Isaacs A; Sleegers K; de Koning I; Zorkoltseva IV; Axenovich TI; Witteman JC; Janssens AC; van Swieten JC; Aulchenko YS; Oostra BA; van Duijn CM
    Neurobiol Aging; 2010 Oct; 31(10):1831-3. PubMed ID: 19004527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of an APOE polymorphism on cognitive function depends on age.
    Shin MH; Kweon SS; Choi JS; Lee YH; Nam HS; Park KS; Kim HN; Song HR; Kim BC; Choi SM; Oh SY; Jeong SK
    J Neurol; 2014 Jan; 261(1):66-72. PubMed ID: 24146255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the APOE-epsilon4 allele and ACE-I/D polymorphism on cognition during a two-year follow-up in first-ever stroke patients.
    Bour AM; Rasquin SM; Baars L; van Boxtel MP; Visser PJ; Limburg M; Verhey FR
    Dement Geriatr Cogn Disord; 2010; 29(6):534-42. PubMed ID: 20606435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: a retrospective baseline analysis of a national dataset.
    Kalapatapu RK; Delucchi KL
    Am J Drug Alcohol Abuse; 2013 Jul; 39(4):219-26. PubMed ID: 23808899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants.
    Lyall DM; Ward J; Ritchie SJ; Davies G; Cullen B; Celis C; Bailey ME; Anderson J; Evans J; Mckay DF; Mcintosh AM; Sattar N; Smith DJ; Deary IJ; Pell JP
    Age Ageing; 2016 Jul; 45(4):511-7. PubMed ID: 27103599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
    Knopman DS; Mosley TH; Catellier DJ; Coker LH;
    Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
    Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
    van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
    Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia.
    Tsai SJ; Gau YT; Liu ME; Hsieh CH; Liou YJ; Hong CJ
    Neurosci Lett; 2008 Mar; 433(2):158-62. PubMed ID: 18242855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein isoform E4 does not increase coronary heart disease risk in carriers of low-density lipoprotein receptor mutations.
    Versmissen J; Oosterveer DM; Hoekstra M; Out R; Berbée JF; Blommesteijn-Touw AC; van Vark-van der Zee L; Vongpromek R; Vanmierlo T; Defesche JC; Mulder M; Kastelein JJ; Sijbrands EJ
    Circ Cardiovasc Genet; 2011 Dec; 4(6):655-60. PubMed ID: 22010136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
    Batterham PJ; Bunce D; Cherbuin N; Christensen H
    Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.